Pneumococcal disease in western Europe: Burden of disease, antibiotic resistance and management

European Journal of Pediatrics

Volumn 161, Issue 4, 2002, Pages 188-195

  Cartwright, Keith ^a  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Epidemiology; Streptococcus pneumoniae; Transmission; Vaccine

Indexed keywords

PENICILLIN G; PNEUMOCOCCUS VACCINE;

AGE; ANTIBIOTIC RESISTANCE; BACTEREMIA; CLINICAL TRIAL; DRUG EFFICACY; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE RESPONSE; INFECTION RISK; MENINGITIS; MORBIDITY; MORTALITY; OTITIS MEDIA; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEROTYPE; SINUSITIS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; WESTERN EUROPE; CHILD; DRUG RESISTANCE; EUROPE; HEALTH; HEALTH SURVEY; INCIDENCE; INFANT; NEWBORN;

CHILD; DRUG RESISTANCE; EUROPE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE; WORLD HEALTH;

EID: 0036009312     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-001-0907-3     Document Type: Review

References (62)

1. Policy statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis
2. Antimicrobial resistance in Streptococcus pneumoniae: An overview
3. Carriage of antibiotic-resistant Streptococcus pneumoniae by children in eastern and central Europe: A multicenter study with use of standardized methods
4. Some aspects of the pneumococcal carrier state
5. Efficacy, safety, and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
6. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the centers for disease control and prevention's pneumococcal sentinel surveillance system
7. Epidemiology of emerging pneumococcal drug resistance: Implications for treatment and prevention
8. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
9. Pneumococcal disease
10. Carriage of multiresistant Streptococcus pneumoniae among children attending day-care centres in the Stockholm area
11. Consensus statement: Establishing reimbursement guidelines for Pnc7, a new pediatric vaccine for Streptococcus pneumoniae
12. Molecular epidemiological survey of penicillin-resistant Streptococcus pneumoniae from Asia, Europe, and North America
13. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 Results from the SENTRY antimicrobial surveillance program
14. Antibody response to pneumococcal vaccination in children younger than five years of age
15. Resistant pneumococci: Protecting patients through judicious use of antibiotics
16. Acute otitis media: Management and surveillance in an era of pneumococcal resistance-a report from the drug-resistant Streptococcus pneumoniae therapeutic working group
17. Bacteraemic pneumococcal infections in Southern Sweden 1981-96: Trends in incidence, mortality, age-distribution, serogroups, and penicillin-resistance
18. Epidemiology of pneumococcal infections in Swedish children
19. Epidemiology of invasive pneumococcal infections in children in Finland
20. Efficacy of a pneumococcal conjugate vaccine against acute otitis media
21. Pneumococcal vaccine
22. Streptococcus pneumoniae in children in Spain: 1990-1999
23. Epidemiology of pneumococcal infections in French children
24. Pathogens isolated during treatment failures in otitis
25. Streptococcus pneumoniae: Serotypes, invasive and antibiotic resistant strains: The current situation in France
26. Marked differences in pneumococcal carriage and resistance patterns between day care centers located within a small area
27. Epidemiologic studies of Streptococcus pneumoniae in infants: Acquisition, carriage, and infection during the first 24 months of life
28. The epidemiology of pneumococcal infection in children in the developing world
29. Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I
30. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: Multinational study of 917 children with acute otitis media
31. The incidence of neonatal pneumococcal septicemia in Sweden 1991-92. The result of a national survey
32. Epidemiology of Streptococcus pneumoniae infections at the Edinburgh City Hospital: 1980-95
33. Epidemiology of invasive pneumococcal infections in children aged 0-6 years in Denmark: A 19-year nationwide surveillance study
34. New vaccines for the prevention of pneumococcal infections
35. Parallel evaluation of the effect of a 7-valent pneumococcal conjugate vaccine (PNCCRM) on pneumococcal (PNC) carriage and acute otitis media (AOM)
36. Antimicrobial resistance in Streptococcus pneumoniae: A South African perspective
37. Nasopharyngeal carriage of multidrug-resistant Streptococcus pneumoniae in institutionalized HIV-infected and HIV-negative children in northeastern Romania
38. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990)
39. Epidemiological study of Streptococcus pneumoniae carriers in healthy primary-school children
40. Evolution of the bacteriologic features of persistent acute otitis media compared with acute otitis media: A 15-year study
41. Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children
42. Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998
43. Acute bacterial meningitis in children admitted to the Queen Elizabeth Central Hospital, Blantyre, Malawi in 1996-1997
44. Population biology of Streptococcus pneumoniae isolated from oropharyngeal carriage and invasive disease
45. Effect of a 7-valent pneumococcal conjugate vaccine on nasopharyngeal (NP) carriage among Navajo and White Mountain Apache (N/WMA) infants
46. Otitis media and child development: Should we worry?
47. Pneumococcal meningitis and bacteraemia in Danish children 1969-1978. Serotypes, incidence, and outcome
48. Epidemiology of Streptococcus pneumoniae in Italian children
49. Resistance patterns of Streptococcus pneumoniae from children in central Italy
50. Serogroup-specific epidemiology of Streptococcus pneumoniae: Associations with age, sex, and geography in 7,000 episodes of invasive disease
51. Outcome of invasive pneumococcal disease: A UK based study
52. Changing epidemiology of bacterial meningitis in the United States
53. Potential interventions for the prevention of childhood pneumonia: Geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children-implications for vaccine strategies
54. Epidemiology of meningitis and bacteraemia due to Streptococcus pneumoniae in The Netherlands
55. Epidemiology of invasive childhood pneumococcal infections in Greece
56. Risk factors for primary invasive pneumococcal disease among children in Finland
57. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae
58. Preventing pneumococcal disease among infants and young children
59. Paediatric invasive pneumococcal disease in Switzerland 1985-1994
60. Pneumococcal vaccines. WHO position paper
61. Epidemiology of pneumococcal disease in children in Germany